Navigation Links
The quest for a better bionic hand
Date:2/17/2013

For an amputee, replacing a missing limb with a functional prosthetic can alleviate physical or emotional distress and mean a return of vocational ability or cosmetics. Studies show, however, that up to 50 percent of hand amputees still do not use their prosthesis regularly due to less than ideal functionality, appearance, and controllability. But Silvestro Micera, of the cole Polytechnique Fdrale de Lausanne (EPFL) in Switzerland, is paving the way for new, smart prosthetics that connect directly to the nervous system. The benefits are more versatile prosthetics with intuitive motor control and realistic sensory feedbackin essence, they could one day return dexterity and the sensation of touch to an amputee.

At the 2013 Annual Meeting of the American Association for the Advancement of Science (AAAS) in Boston, Micera reports the results of previous work conducting a four-week clinical trial that improved sensory feedback in amputees by using intraneural electrodes implanted into the median and ulnar nerves. This interface holds great promise because of its ability to create an intimate and natural connection with the nerves, and because it is less invasive than other methods. It also provides fast, intuitive, bidirectional flow of information between the nervous system and the prosthetic, resulting in a more realistic experience and ultimately improved function.

"We could be on the cusp of providing new and more effective clinical solutions to amputees in the next years," says Micera, who is Head of the Translational Neural Engineering Laboratory at EPFL and Professor at the Scuola Superiore Sant'Anna in Italy. Micera and colleagues tested their system by implanting intraneural electrodes into the nerves of an amputee. The electrodes stimulated the sensory peripheral system, delivering different types of touch feelings. Then the researchers analyzed the motor neural signals recorded from the nerves and showed that information related to grasping could indeed be extracted. That information was then used to control a hand prosthesis placed near the subject but not physically attached to the arm of the amputee.

At AAAS in Boston, Micera also describes his recent activities to improve the efficacy of this approach and announces a new clinical trial starting soon as part of the Italian Ministry of Health's NEMESIS project, under the clinical supervision of Prof. Paolo M. Rossini. This new trial carries this research a step further by connecting the prosthetic hand directly to the patient for the first real-time, bidirectional control using peripheral neural signals. Though results are not yet available, the researchers hope to find still further improvement in the sensory feedback and overall control of the prosthetics with this new method.


'/>"/>

Contact: Hillary Sanctuary
hillary.sanctuary@epfl.ch
41-797-034-809
Ecole Polytechnique Fdrale de Lausanne
Source:Eurekalert

Related biology technology :

1. Distinct Bright Answers Questions on Why Bacteria are Becoming Resistant to Antibiotics
2. How to Answer 20 Tough Medical Sales Job Interview Questions from Nationally Renowned Career Coach, Peggy McKee, CEO of Career Confidential
3. Quest Diagnostics Clinical Trials Biorepository Accredited by the College of American Pathologists
4. Physicians Answer Questions About Food Biotechnology in IFIC Foundation Videos
5. Maths experts question key ecological theory
6. Questcor Pharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference
7. Questcor Pharmaceuticals Expands Repurchase Program
8. Quest Diagnostics Announces C9orf72 Genetic Test for ALS (Lou Gehrigs Disease)
9. Mars, Incorporated Answers Question: How Does Feeding People and Pets Nurture Science and Discovery? At TEDMED 2012
10. Questcor Pharmaceuticals to Present at the Leerink Swann Global Healthcare Conference on February 16, 2012
11. Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... , Feb. 16, 2017  Rhythm, ... rare genetic deficiencies that result in life-threatening ... a $41 million mezzanine round of financing ... OrbiMed, MPM Capital, New Enterprise Associates, Pfizer ... undisclosed public healthcare investment fund. Rhythm will ...
(Date:2/15/2017)... Clara, CA (PRWEB) , ... February 15, 2017 , ... ... announced that Park SmartScan, a powerful AFM operating software that drastically boosts productivity with ... SmartScan completely automatizes all of the functions of setting up and taking the image ...
(Date:2/15/2017)... WARRINGTON, Pa. , Feb. 15, 2017 /PRNewswire/ ... ), a biotechnology company focused on developing aerosolized ... that it has completed a $10.5 million private ... expects that it has sufficient capital to fund ... 2b clinical trial data release in mid-2017. ...
(Date:2/15/2017)... , Feb. 15, 2017  Surrozen Inc., a ... drugs that promote the repair and regeneration of human ... led by The Column Group, a science-driven venture capital ... The funds will be used to implement a broad-based ... of Wnt signaling, which plays a central role in ...
Breaking Biology Technology:
(Date:2/8/2017)... YORK , Feb. 7, 2017 ... Driven largely by the confluence of organizations, desires ... distaste for knowledge-based systems (password and challenge questions), ... industrial, and government systems. The market is driven ... a demarcation between consumer and enterprise uses cases, ...
(Date:2/6/2017)... 2017 According to Acuity Market Intelligence, ... authorities to continue to embrace biometric and digital ... Automated Border Control (ABC) eGates and 1436 Automated ... than 163 ports of entry across the globe. ... a combined CAGR of 37%. APC Kiosks reached ...
(Date:2/2/2017)... -- Central to its deep commitment to honor the ... Prize Foundation today announced the laureates of the ... in their respective fields of Life Sciences and ... recognized with the 2017 Japan Prize for original ... the advancement of science and technology, but also ...
Breaking Biology News(10 mins):